|
|
Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol.
E. Bernichon
,
A. Vallard
,
Qiang Wang
,
Valéry Attignon
,
Daniel Pissaloux
et al.
Journal articles
hal-01610114v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial
Alice Bonneville-Levard
,
Didier Frappaz
,
Olivier Tredan
,
Emilie Lavergne
,
Véronique Corset
et al.
Journal articles
hal-03915456v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Tumor Molecular Profiling: Pediatric Results of the ProfiLER Study
Sarah Benezech
,
Pierre Saintigny
,
Valery Attignon
,
Daniel Pissaloux
,
Sandrine Paindavoine
et al.
Journal articles
hal-03851844v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Epidermal Growth Factor Receptor Mediates the Vascular Dysfunction But Not the Remodeling Induced by Aldosterone/Salt
Violaine Griol-Charhbili
,
Céline Fassot
,
Smail Messaoudi
,
Claudine Perret
,
Vincent Agrapart
et al.
Journal articles
hal-02510370v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer
F Campone
,
F Bachelot
,
F. Penault-Llorca
,
F Pallis
,
F Agrapart
et al.
Journal articles
hal-02089814v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
Olivier Trédan
,
Qiang Wang
,
Daniel Pissaloux
,
Pierre Cassier
,
Arnaud de La Fouchardière
et al.
Journal articles
hal-02367110v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|